Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05113628
Other study ID # Methylene blue
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2020
Est. completion date July 15, 2021

Study information

Verified date October 2021
Source Zagazig University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative complications. The most distressing complications are recurrent laryngeal nerve and parathyroid injuries. Methylene blue spray is a technique than can be used for easy identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their injuries.


Description:

Thyroid disorders constitute the second most common endocrine disease following diabetes mellitus. Thyroid surgery is one of the most frequently operated Head and Neck surgeries. Post-thyroidectomy complications are not uncommon. Parathyroids and Recurrent Laryngeal Nerve (RLN) are two of the complications of thyroidectomy that cause significant postoperative morbidity Due to the advances in thyroids surgeries, the occurrence of postoperative complications has been decreased, but when occurred, they cause lifelong handicap. The most important complications encountered are injury to the RLN and parathyroids. Meticulous dissection is a key factor in minimizing the occurrence of complications During thyroidectomy, careful dissection can protect the parathyroid glands and RLN. Various methods were used including capsular dissection, attention to protection of the arterial supply to parathyroids, avoiding unnecessary manipulation in the area of RLN Methylene blue spraying is a new technique that allows identification of both parathyroid glands and recurrent laryngeal nerves


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date July 15, 2021
Est. primary completion date June 10, 2021
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Age of 16 years and older. - Both sexes. - Patients who are candidate for thyroid surgery and euthyroid. Exclusion Criteria: - - Patients with hyper- or hypo-thyroid status. - Patients who were unfit for surgery. - Patients with unilateral or bilateral vocal cord palsy on preoperative indirect laryngoscopy - Patients with thyroid malignancy by preoperative FNAC. - Patients with hypersensitivity to methylene blue were excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
methylene blue identification
After ligation of the middle thyroid vein and the upper pole of the thyroid, the thyroid lobe was retracted medially and diluted methylene blue (0.5 ml methylene blue 2% was diluted by 5ml normal saline) was sprayed over the lower thyroid pole and the perilobar area. This area contains structures including recurrent laryngeal nerve, parathyroid glands, and inferior thyroid vessels which were observed After spraying. The vocal cord mobility was assessed intraoperatively by the anesthesiologist at time of extubation. The serum calcium was measured on the 2nd postoperative day. There was no routine use of postoperative calcium supplementation. Hypocalcemia was defined when the serum calcium level was less than 8 mg/dl.

Locations

Country Name City State
Egypt Zagazig university hospitals Zagazig

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary detection of the recurrent larngeal nerve unstained the methylene blue dye stain the background and the RLN appears unstained one minute after dye application
Primary detection of the parathyroig glands the methylene blue dye stain washed out and the parathyroid gland remained stained after 3 minutes 3 minutes after dye application
See also
  Status Clinical Trial Phase
Recruiting NCT03680222 - Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery N/A
Recruiting NCT03530033 - Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring N/A
Recruiting NCT06406725 - Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure
Recruiting NCT04994964 - Recurrent Nerve Monitoring During Aortic Arch Repair N/A
Recruiting NCT06289309 - NerveTrend vs. NerveAssure in Prevention of Recurrent Laryngeal Nerve Injury During Thyroid Surgery N/A
Completed NCT04379804 - CRANIO-CAUDAL AND LATERAL APPROACH FOR RECURRENT LARYNGEAL NERVE N/A
Completed NCT02493881 - Recurrent Laryngeal Nerve's Motor Function: Sometimes Motor Fibers May Also Be Located in The Posterior Branch N/A
Not yet recruiting NCT05684536 - Comparison of Liagure Safety in Thyroidectomy With Conventional Thyroidectomy N/A
Completed NCT03907761 - Hydrodissection of Recurrent Laryngeal Nerve: Case Series
Recruiting NCT06348381 - Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation
Recruiting NCT04794257 - NerveTrend vs. i-IONM in Prevention of Recurrent Laryngeal Nerve Events During Bilateral Thyroid Surgery. N/A